NFκB is involved in several pathogenic mechanisms that are believed to underlie the complex regional pain syndrome (CRPS), including ischemia, inflammation and sensitization. Chronic post-ischemia pain (CPIP) has been developed as an animal model that mimics the symptoms of CRPS-I. The possible involvement of NFκB in CRPS-I was studied in CPIP rats. Under sodium pentobarbital anesthesia a tourniquet was placed around the rat left ankle joint, producing 3 h ours of ischemia, followed by rapid reperfusion (IR Injury). NFκB was measured in nuclear extracts of muscle and spinal cord tissue using ELISA. Moreover, the anti-allodynic (mechanical and cold) effect was tested for systemic, intrathecal, or intraplantar treatment with the NFkB inhibitor pyrrolidine dithiocarbamate (PDTC). At 2 and 48 hrs after IR injury, NFκB was elevated in muscle and spinal cord of CPIP rats compared to sham rats. At 7 days, NFκB levels were normalized in muscle, but were still elevated in spinal cord tissue. Systemic PDTC treatment relieved mechanical and cold allodynia in a dose-dependent manner, lasting for at least three hours. Intrathecal --but not intraplantar --administration also relieved mechanical allodynia. The results suggest that muscle and spinal NFκB plays a role in the pathogenesis of CPIP and potentially of human CRPS.